About Me
About Me
My name is Cornelius Enuezie and I am the founder of COZAREN GmbH and I come with over 27 years of biopharmaceutical experience (notably, at Novartis, IMS Health, Teva and Clarivate). I have an excellent record of generating economic value by leveraging patent portfolio and technical knowledge and implementing portfolio optimisation strategies to identify hidden patent monetisation opport​unities, increase patent portfolio value and reduce management costs, thus enabling organisations to focus on core business strengths and interests.
For more my LinkedIn profile, please click here.
Qualifications:
- Doctorate in Business Administration (DBA);
- Master of Laws (LLM) in Patent and Technology Law; and,
- Bachelor of Science degree in Industrial Chemistry.
I also have expert knowledge of myriad pharmaceutical information and patent searching databases, including CAS Registry, DWPI, SequenceBase (GENESEQ), Cortellis, Cortellis Drug Discovery Intelligence (CDDI) and GlobalData databases, as well freely-available patent databases provided by patent offices. Please refer to my areas of expertise below.
Publications:
Click here for my latest article in les Nouvelles on Business research skills for facilitating non-core out-licensing, which was voted the article of the month of October 2021.
Portfolio management
Portfolio management
- portfolio audits to identify licensing/monetisation opportunities and areas for achieving cost savings;
- biopharmaceutical competitor and market intelligence analyses;
- patent portfolio valuations;
- clinical and regulatory insights into biopharmaceutical R&D activities; and
- product pricing and forecasting analyses.
Commercial research
Commercial research
- licensees, new markets and R&D collaborators;
- untapped R&D and commercial opportunities; and,
- litigation/infringement risks.
Patent search
Patent search
- chemical and biological novelty, validity, landscape and FTO searches.
Case law to:
Case law to:
- support patent prosecution and litigation;
- conduct due diligence, risk analyses (including anti-trust scrutiny); and,
- prepare business and legal case to support patent infringement enforcement.